THERESA MELTZ: Open Payments
NPI 1083654297 · HUDSON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,232 in 79 payments from 20 companies in 2025. Trend: 2023 $1,442 · 2024 $1,259 · 2025 $1,232
Food & beverage: $1,232
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 19 | $230 |
| Novo Nordisk Inc | 17 | $171 |
| PFIZER INC. | 12 | $157 |
| ABBVIE INC. | 3 | $102 |
| Amgen Inc. | 5 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $44 |
| Lundbeck LLC | 2 | $43 |
| Verona Pharma, Inc. | 2 | $42 |
Products named: ELIQUIS, TRELEGY ELLIPTA, EVENITY, SHINGRIX, UBRELVY, REXULTI, GEMTESA, Kerendia.
Industry payments across NY — which companies pay providers there.
